Secor Capital Advisors’s Celgene Corp CELG Stock Holding History

Secor Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	-$74	–	667
2018 Q3	$0	Sell	1 -17,968	-100%	-$1.59M	﹤0.01%	653
2018 Q2	$1.43M	Buy	+17,969	New	+$1.49M	0.12%	255
2018 Q1	–	Sell	-29,628	Closed	-$2.84M	–	724
2017 Q4	$3.09M	Buy	+29,628	New	+$3.34M	0.12%	140
2016 Q4	–	Sell	-29,502	Closed	-$3.29M	–	721
2016 Q3	$3.08M	Buy	+29,502	New	+$3.19M	0.34%	90
2016 Q2	–	Sell	-12,941	Closed	-$1.34M	–	810
2016 Q1	$1.29M	Buy	+12,941	New	+$1.33M	0.18%	121
2015 Q4	–	Sell	-3,200	Closed	-$370K	–	725
2015 Q3	$346K	Buy	+3,200	New	+$397K	0.11%	317

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Secor Capital Advisors's CELG Position: Q4 2018 in Review

Secor Capital Advisors sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 1 share — an estimated $74 sold.

Secor Capital Advisors first reported a position in CELG in Q3 2015 and held it in 6 quarters. The position peaked at $3.09M in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

Secor Capital Advisors reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
Secor Capital Advisors sold 1 Celgene Corp share in Q4 2018, an estimated $74.
Secor Capital Advisors first reported a position in Celgene Corp in Q3 2015 and held it in 6 quarters.
Secor Capital Advisors's Celgene Corp position peaked at $3.09M in Q4 2017.
1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.